BiotechTube

Albuterol Sulfate HFA 0.09 mg (Reference) + Albuterol Sulfate HFA 0.18 mg (Reference) + Albuterol Sulfate HFA 0.09 mg (Test) + Albuterol Sulfate HFA 0.18 mg (Test) + Placebo

Phase 3Withdrawn
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bronchial Asthma

Conditions

Bronchial Asthma

Trial Timeline

Apr 1, 2022 → Dec 1, 2022

NCT ID
NCT05292976

About Albuterol Sulfate HFA 0.09 mg (Reference) + Albuterol Sulfate HFA 0.18 mg (Reference) + Albuterol Sulfate HFA 0.09 mg (Test) + Albuterol Sulfate HFA 0.18 mg (Test) + Placebo

Albuterol Sulfate HFA 0.09 mg (Reference) + Albuterol Sulfate HFA 0.18 mg (Reference) + Albuterol Sulfate HFA 0.09 mg (Test) + Albuterol Sulfate HFA 0.18 mg (Test) + Placebo is a phase 3 stage product being developed by Aurobindo Pharma for Bronchial Asthma. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT05292976. Target conditions include Bronchial Asthma.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT05292976Phase 3Withdrawn

Competing Products

20 competing products in Bronchial Asthma

See all competitors
ProductCompanyStageHype Score
TacrolimusAstellas PharmaPhase 2
52
tacrolimusAstellas PharmaPhase 2
52
Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation) + Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1 + Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2 + PlaceboCiplaPhase 3
77
90 mcg Reference Product + 180 mcg Reference Product + 90 mcg Test Product + PlaceboCiplaPhase 3
77
Fluticasone propionate/salmeterol 100/50 µg + Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUATCiplaPhase 3
77
Test Product + Reference Product + PlaceboAurobindo PharmaPhase 3
77
Fluticasone propionate Inhalation Aerosol 44 mcg + FLOVENT HFA 44 mcg + Matching Placebo inhalerGlenmark PharmaceuticalsPhase 3
77
Symbicort Turbuhaler + Symbicort pMDI + Pulmicort TurbuhalerAstraZenecaPhase 3
77
RoflumilastAstraZenecaPhase 3
77
RoflumilastAstraZenecaPhase 2/3
65
Symbicort (budesonide/formoterol) Turbuhaler + Conventional treatmentAstraZenecaPhase 3
77
CiclesonideAstraZenecaPhase 3
77
Montelukast plus prednisolone + PrednisoloneMerckPhase 2
52
MontelukastMerckApproved
85
Formoterol fumerate + fenoterol/ipratropium bromideNovartisApproved
85
inhaled corticosteroid therapyNovartisPhase 1/2
41
PF-00610355 + PF - 00610355 + PF - 00610355PfizerPhase 2
51
NivolumabBristol Myers SquibbPhase 2
51
HSK31858 + PlaceboHaisco Pharmaceutical GroupPhase 2
49
HSK31858 + PlaceboHaisco Pharmaceutical GroupPhase 2
49

Other Products from Aurobindo Pharma

Test Product + Reference Product + PlaceboPhase 3
77
Adapalene 0.1% Gel + Differin 0.1% Topical GelPhase 3
77
Amphotericin B Liposome + AmBisome (Amphotericin B) LiposomePhase 1
33
Amlodipine - reference + Amlodipine ODT - test + Amlodipine ODT - testPhase 1
33
Amlodipine - reference + Amlodipine ODT - testPhase 1
33